
Sign up to save your podcasts
Or


We love to hear from our listeners. Send us a message.
Carisma Therapeutics’ Dr. Barton breaks down the latest in CAR-M technology as well as the company's Phase 1 First-in-Human Study of Adenovirally Transduced Anti-HER2 CAR Macrophages in Subjects with HER2 Overexpressing Solid Tumors.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn
By Erin Harris4.9
3838 ratings
We love to hear from our listeners. Send us a message.
Carisma Therapeutics’ Dr. Barton breaks down the latest in CAR-M technology as well as the company's Phase 1 First-in-Human Study of Adenovirally Transduced Anti-HER2 CAR Macrophages in Subjects with HER2 Overexpressing Solid Tumors.
Subscribe to the podcast!
Apple | Spotify | YouTube
Visit my website: Cell & Gene
Connect with me on LinkedIn

3,465 Listeners

754 Listeners

153 Listeners

819 Listeners

113,483 Listeners

10,342 Listeners

336 Listeners

6,581 Listeners

5,662 Listeners

6,445 Listeners

87 Listeners

5,596 Listeners

10,976 Listeners

16 Listeners

1,477 Listeners